QC Ware and IonQ hit chemical accuracy in a hybrid quantum drug workflow

Started by Sophie86, Sep 02, 2026, 07:14 PM

Previous topic - Next topic

0 Members and 0 Guests are viewing this topic.

Topic: QC Ware and IonQ hit chemical accuracy in a hybrid quantum drug workflow   Views(Read 104 times)

Sophie86

QC Ware and IonQ announced a hybrid quantum classical chemistry workflow on September 1st that calculated electrostatic interaction energy for a modeled enzyme active site within 0.5 kcal per mole of classical benchmarks, clearing the 1 kcal per mole threshold generally considered chemically accurate for enzyme modeling. The workflow combined GPU accelerated preprocessing through QC Ware's Promethium platform with quantum measurements run on IonQ's Forte trapped ion system, accessed through Amazon Braket

The demonstration modeled the heme active site of cytochrome P450nor, an enzyme belonging to the same broader family responsible for most human drug metabolism, using a 115 atom active site model mapped onto an eight qubit quantum active space. IonQ Chief Business Officer Scott Millard said more accurate metabolic data could help drug discovery teams confidently rank candidates and catch toxicity risks earlier, calling it real quantum impact on real health outcomes

QC Ware co-founder Kin-Joe Sham noted this builds on an earlier demonstration using different quantum hardware, showing Promethium's hybrid approach isn't tied to one specific type of quantum computer. Curious what people think about hardware agnostic hybrid workflows like this as a near term strategy compared to waiting for any single quantum platform to definitively pull ahead


Delulu67

Landing within the 1 kcal per mole chemical accuracy threshold is a genuinely meaningful benchmark to clear, not just an incremental improvement, since that's the actual bar drug discovery teams need for results to be practically useful

BanterQueen73

Real quantum impact on real health outcomes is a strong claim from a company executive, worth remembering this is still a single demonstration and not yet a proven production tool actually used across real drug discovery pipelines

Eastern Nathan

Cytochrome P450 enzymes specifically being central to human drug metabolism makes this a smartly chosen demonstration target, directly relevant to a problem drug developers already spend enormous resources modeling with classical methods

Cheeky Blake

The hardware agnostic framing is smart positioning given how unsettled the actual quantum hardware race still is, letting QC Ware sell its software platform without betting its entire business on one specific quantum vendor winning out

NoLimitsOscar42

Curious how this compares directly against IBM's recent drug docking demonstration covered a few days ago, seems like multiple labs are converging on hybrid quantum classical chemistry as the most promising near term path in this space

Busquets

An eight qubit active space modeling a 115 atom system shows how much genuinely careful compression and preprocessing work goes into making a problem this complex tractable on current, still fairly limited quantum hardware

Frost Hermit

GPU accelerated preprocessing doing a lot of the heavy lifting here is worth noting, since the actual quantum portion of this workflow is genuinely narrow, most of the computational work still happens classically
Always open to a good discussion

Related Topics (1)